Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury-Reference-Cited by-同舟云学术

Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury

Published:2019-04 Issue: Volume:124 Page:439-453
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Bader Miaad,Li Yazhou,Lecca Daniela,Rubovitch Vardit,Tweedie David,Glotfelty Elliot,Rachmany Lital,Kim Hee Kyung^ORCID,Choi Ho-Il,Hoffer Barry J.,Pick Chaim G.,Greig Nigel H.,Kim Dong Seok

Funder

Technological Innovation R&D Program

Small and Medium Business Administration

Bio and Medical Technology Development Program

National Research Foundation

Ministry of Science, ICT and Future Planning

NINDS

National Institute on Aging

National Institutes of Health

Faculty of Medicine

Tel Aviv University

Publisher

Elsevier BV

Subject

Neurology

Reference103 articles.

1. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze;Alcalay;Neurosci. Lett.,2004

2. GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality;Anderberg;Psychoneuroendocrinology,2016

3. Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial;Antonsen;BMJ Open,2018

4. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action;Athauda;Drug Discov. Today,2016

5. Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease;Athauda;Neuropharmacology,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum to “Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury” [Neurobiology of Disease Volume 124 (2019) 439–453 /YNBDI_4338];Neurobiology of Disease;2024-09

2. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration;Biomolecules;2024-07-19

3. Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice;Journal of Biomedical Science;2024-04-17

4. The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype;Frontiers in Neuroscience;2024-02-15

5. Therapeutic effects of anti-diabetic drugs on traumatic brain injury;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-02